Fangfang Liu

Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma <i>In Vitro</i> and Patient-Derived Xenografts <i>In Vivo</i>

Mengqiu Song, Xuejiao Liu, Kangdong Liu et al. · Molecular Cancer Therapeutics · 2018 · 79 citations · Full text

Medicine, Oncology, Pharmacology +16

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth <i>in vitro</i> and <i>in vivo</i>

Xuejiao Liu, Mengqiu Song, Penglei Wang et al. · International Journal of Cancer · 2019 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo

Seung Ho Shin, Do Young Lim, Kanamata Reddy et al. · EBioMedicine · 2017 · 64 citations · Full text

Medicine, Cancer Biology, Oncology +10

Comparison of restrictive and liberal transfusion strategy on postoperative delirium in aged patients following total hip replacement: A preliminary study

Yunxia Fan, Fangfang Liu, Min Jia et al. · Archives of Gerontology and Geriatrics · 2014 · 58 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression

Qiong Wu, Fangfang Liu, Meng-Meng Ge et al. · Oncogene · 2021 · 51 citations · Full text

Medicine, Molecular Biology, Oncology +9